Pharmacology
 |
|
21 february 2021 14:27:17 |
| M351‐0056 is a novel low MW compound modulating the actions of the immune‐checkpoint protein VISTA (British Journal of Pharmacology) |
|
Tweet British Journal of Pharmacology, EarlyView. |
| 188 viewsCategory: Pharmacology |
 Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis (British Journal of Pharmacology)G‐CSFR antagonism reduces mucosal injury and airways fibrosis in a virus‐dependent model of severe asthma (British Journal of Pharmacology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
